Peanut allergy: Skin patch therapy ‘boosts tolerance’ in toddlers
Though results are promising, its role in clinical care is unclear, says allergy and respiratory physician Dr Celia Zubrinich.
Two-thirds of toddlers with peanut allergy had improved tolerance when treated with epicutaneous immunotherapy, according to results from an international study involving Australian children.
After 12 months, 64% of children given the skin patch containing 250µg of peanut protein could tolerate a 1000mg food challenge, regardless of baseline severity, compared to just 30% of those given placebo.
